278 related articles for article (PubMed ID: 30091820)
1. The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice.
Kim M; Custodio RJ; Botanas CJ; de la Peña JB; Sayson LV; Abiero A; Ryoo ZY; Cheong JH; Kim HJ
Addict Biol; 2019 Sep; 24(5):946-957. PubMed ID: 30091820
[TBL] [Abstract][Full Text] [Related]
2. The differential vulnerabilities of Per2 knockout mice to the addictive properties of methamphetamine and cocaine.
Sayson LV; Lee HJ; Ortiz DM; Kim M; Custodio RJP; Lee CH; Lee YS; Cheong JH; Kim HJ
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Aug; 126():110782. PubMed ID: 37141987
[TBL] [Abstract][Full Text] [Related]
3. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
[TBL] [Abstract][Full Text] [Related]
4. The role of tissue plasminogen activator in methamphetamine-related reward and sensitization.
Nagai T; Noda Y; Ishikawa K; Miyamoto Y; Yoshimura M; Ito M; Takayanagi M; Takuma K; Yamada K; Nabeshima T
J Neurochem; 2005 Feb; 92(3):660-7. PubMed ID: 15659235
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
Itzhak Y; Martin JL; Ali SF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
[TBL] [Abstract][Full Text] [Related]
7. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
[TBL] [Abstract][Full Text] [Related]
8. The role of striatal Gα
Lee KW; Kim K; Kim HC; Lee SY; Jang CG
Behav Brain Res; 2018 Jul; 346():66-72. PubMed ID: 29223637
[TBL] [Abstract][Full Text] [Related]
9. Adenosine 2A receptors modulate reward behaviours for methamphetamine.
Chesworth R; Brown RM; Kim JH; Ledent C; Lawrence AJ
Addict Biol; 2016 Mar; 21(2):407-21. PubMed ID: 25612195
[TBL] [Abstract][Full Text] [Related]
10. Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.
Horio M; Kohno M; Fujita Y; Ishima T; Inoue R; Mori H; Hashimoto K
PLoS One; 2012; 7(4):e35494. PubMed ID: 22530033
[TBL] [Abstract][Full Text] [Related]
11. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice.
Mizoguchi H; Yamada K; Niwa M; Mouri A; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
J Neurochem; 2007 Mar; 100(6):1579-88. PubMed ID: 17348864
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin deficiency on the rewarding properties of methamphetamine in streptozotocin-induced diabetic rats.
Bayat AH; Haghparast A
Pharmacol Biochem Behav; 2015 Jan; 128():8-13. PubMed ID: 25444864
[TBL] [Abstract][Full Text] [Related]
13. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
[TBL] [Abstract][Full Text] [Related]
14. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity.
Nakajima A; Yamada K; Nagai T; Uchiyama T; Miyamoto Y; Mamiya T; He J; Nitta A; Mizuno M; Tran MH; Seto A; Yoshimura M; Kitaichi K; Hasegawa T; Saito K; Yamada Y; Seishima M; Sekikawa K; Kim HC; Nabeshima T
J Neurosci; 2004 Mar; 24(9):2212-25. PubMed ID: 14999072
[TBL] [Abstract][Full Text] [Related]
15. The role of thioredoxin-1 in resisting methamphetamine-induced rewarding effect.
Huang M; Kong L; Yang L; Li X; Zhou X; Li Y; Bai J
Behav Brain Res; 2018 Jan; 337():280-286. PubMed ID: 28782589
[TBL] [Abstract][Full Text] [Related]
16. Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine.
Bäckman C; You ZB; Perlmann T; Hoffer BJ
Behav Brain Res; 2003 Jul; 143(1):95-100. PubMed ID: 12842300
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine treatment causes delayed decrease in novelty-induced locomotor activity in mice.
Krasnova IN; Hodges AB; Ladenheim B; Rhoades R; Phillip CG; Cesena A; Ivanova E; Hohmann CF; Cadet JL
Neurosci Res; 2009 Oct; 65(2):160-5. PubMed ID: 19559060
[TBL] [Abstract][Full Text] [Related]
18. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.
Shen X; Purser C; Tien LT; Chiu CT; Paul IA; Baker R; Loh HH; Ho IK; Ma T
J Neurosci Res; 2010 Aug; 88(10):2294-302. PubMed ID: 20209629
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal neurogenesis interferes with extinction and reinstatement of methamphetamine-associated reward memory in mice.
Che X; Bai Y; Cai J; Liu Y; Li Y; Yin M; Xu T; Wu C; Yang J
Neuropharmacology; 2021 Sep; 196():108717. PubMed ID: 34273388
[TBL] [Abstract][Full Text] [Related]
20. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
Itzhak Y; Ali SF
Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
